Reports & Presentations

Regulatory

2021-03-30 | Ascelia Pharma publishes Annual Report for 2020

Regulatory

2021-02-16 | Quarterly Report Q4 2020: Mangoral shows high diagnostic value in new study

Regulatory

2020-11-05 | Quarterly Report Q3-2020: Raised market estimate for Mangoral and preparing for market launch

Regulatory

2020-08-20 | Quarterly Report Q2-2020: First participant in the hepatic study

Regulatory

2020-05-13 | Interim Financial Report Q1-2020: First patient enrolled in Phase 3 study SPARKLE

Regulatory

2020-04-06 | Ascelia Pharma publishes Annual Report for the financial year 2019

Regulatory

2020-02-14 | 2019 year-end financial report: Sites opened for recruitment to the pivotal Phase III study SPARKLE

Regulatory

2019-11-08 | Preparations for Phase III study with Mangoral[®] on track

Regulatory

2019-10-14 | Ascelia Pharma publishes Annual Report for the financial year 2018/2019

Regulatory

2019-08-22 | Phase III study of Mangoral to start in H2-2019

Regulatory

2019-05-15 | Fully financed Phase III program for Mangoral through the IPO

About us

Ascelia Pharma is a biotech company focused on orphan oncology treatments. We develop and commercialize novel drugs that address unmet medical needs and have a clear development and market pathway.

Headquarter is in Malmö, Sweden, and the company’s shares are listed on Nasdaq Stockholm (ticker: ACE)

Download our fact sheet: Ascelia Pharma Factsheet Dec 2020

About us

Latest presentations

Ascelia Pharma company presentation March 2021

Capital Markets Day

Capital markets day 21 Oct

Oncoral development: Phase 2 and onwards

Oncoral Phase 2 plans

Reports & Presentations

Latest news

2021-04-09Issue and repurchase of series C shares for share saving program
2021-03-31NOTICE OF ANNUAL GENERAL MEETING IN ASCELIA PHARMA AB
2021-03-31Number of shares and votes in Ascelia Pharma AB
2021-03-30Ascelia Pharma publishes Annual Report for 2020
2021-03-17Notice of extraordinary general meeting in Ascelia Pharma

Press releases & News

Events

April 28 @ 11:15 - 11:35
Redeye Orphan Drugs Seminar – April 2021
May 5 @ 14:00 - 16:00
Annual General Meeting 2021
May 12 @ 08:00
Interim Report Q1 2021 (January-March 2021)
May 25
ABGSC Life Science Summit
August 19 @ 08:00
Half-year report 2021 (April-June 2021)

Events